XML 79 R53.htm IDEA: XBRL DOCUMENT v3.22.0.1
Derivative Financial Instruments (Tables)
12 Months Ended
Dec. 31, 2021
Derivative Financial Instruments  
Amounts related to cumulative basis adjustments for fair value hedges

($ in millions)

At December 31:

    

2021

    

2020

Short-term debt

 

  

 

  

Carrying amount of the hedged item

 

$

(227)

 

$

(1,302)

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)

(2)

(2)

Long-term debt

Carrying amount of the hedged item

 

(508)

 

(2,097)

Cumulative hedging adjustments included in the carrying amount—assets/(liabilities)*

(309)

(424)

* Includes ($302) million and ($353) million of hedging adjustments on discontinued hedging relationships at December 31, 2021 and 2020, respectively.

Effect of derivative instruments in the consolidated income statement

($ in millions)

Gains/(Losses) of

Total

 

Total Hedge Activity

For the year ended December 31:

    

2021

    

2020

2019

2021

    

2020

    

2019

Cost of services

 

$

19,147

$

17,689

$

19,009

$

43

$

23

$

68

Cost of sales

6,184

6,048

*

6,467

*

(16)

2

51

Cost of financing

534

577

*

704

*

1

12

(42)

SG&A expense

18,745

20,561

18,724

176

141

267

Other (income) and expense

873

802

(1,012)

(205)

101

(15)

Interest expense

1,155

1,288

1,344

3

35

(93)

* Reclassifed to conform to 2021 presentation.

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement

Consolidated

Recognized on

Attributable to Risk

Income Statement

Derivatives

Being Hedged (2)

For the year ended December 31:

    

 Line Item

    

2021

    

2020

    

2019

    

2021

    

2020

    

2019

Derivative instruments in fair value hedges (1)

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

Cost of financing

 

$

(1)

$

20

$

44

$

18

$

4

$

(32)

 

Interest expense

 

(2)

58

98

53

11

(71)

Derivative instruments not designated as hedging instruments

 

Foreign exchange contracts

 

Other (income)
and expense

 

(48)

1

(53)

N/A

N/A

N/A

Equity contracts

 

SG&A expense

 

201

142

214

N/A

N/A

N/A

Total

 

  

$

150

$

220

$

302

$

71

$

14

$

(103)

($ in millions)

Gain/(Loss) Recognized in Consolidated Income Statement and Other Comprehensive Income

Consolidated

Reclassified

Amounts Excluded from

For the year ended

Recognized in OCI  

Income Statement 

from AOCI  

Effectiveness Testing (3)

December 31:

   

2021

   

2020

   

2019

   

 Line Item

   

2021

   

2020

   

2019

   

2021

   

2020

   

2019

Derivative instruments in cash flow hedges

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Interest rate contracts

 

$

$

$

(168)

 

Cost of financing

$

(4)

$

(5)

$

(3)

$

$

$

 

Interest expense

(13)

(13)

(8)

Foreign exchange contracts

344

(349)

(521)

 

Cost of services

43

23

68

 

Cost of sales

(16)

2

51

 

Cost of financing

(18)

(23)

(86)

 

SG&A expense

(24)

0

53

 

Other (income)
and expense

(157)

101

39

 

Interest expense

(52)

(65)

(190)

Instruments in net investment hedges (4)

 

  

Foreign exchange contracts

1,644

(2,127)

(95)

 

Cost of financing

6

16

35

 

Interest expense

17

45

77

Total

$

1,989

$

(2,477)

$

(784)

 

  

$

(243)

$

21

$

(75)

$

23

$

60

$

112

(1)

The amount includes changes in clean fair values of the derivative instruments in fair value hedging relationships and the periodic accrual for coupon payments required under these derivative contracts.

(2)

The amount includes basis adjustments to the carrying value of the hedged item recorded during the period and amortization of basis adjustments recorded on de-designated hedging relationships during the period.

(3)

The company’s policy is to recognize all fair value changes in amounts excluded from effectiveness testing in net income each period.

(4)

Instruments in net investment hedges include derivative and non-derivative instruments with the amounts recognized in OCI providing an offset to the translation of foreign subsidiaries.

N/A–Not applicable